| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6176240 | European Urology | 2015 | 9 Pages |
Abstract
Hypofractionation for prostate cancer delivers relatively high doses of radiation per treatment. Prospective studies support the safety of moderate hypofractionation, while extreme fractionation may have greater toxicity. Both show promising cancer control but long-term results of noninferiority studies of both methods are required before use in routine treatment outside of clinical protocols.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Bridget F. Koontz, Alberto Bossi, Cesare Cozzarini, Thomas Wiegel, Anthony D'Amico,